-
-
-
-
-
-
-
Torex Gold Reports Q3 2026 Production Results
-
-
-
-
-
-
-
Jury finds Parse Biosciences willfully infringed 10x Genomics patents
-
-
-
-
-
-
-
Canaccord Reiterates Buy Rating on 10X Genomics (TXG)
-
-
-
-
-
-
-
10X Genomics (TXG) PT Raised to $22 at Canaccord Genuity
-
-
-
-
-
-
-
CareDx partners with 10x Genomics on transplant rejection research program
-
-
-
-
-
-
-
Piper Sandler Starts 10X Genomics (TXG) at Neutral
-
-
-
-
-
-
-
10X Genomics (TXG) PT Lowered to $15 at Canaccord Genuity
-
483,120 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


